Advanced materials for gene delivery

Advanced Materials Research

Volumn 995, Issue , 2014, Pages 29-47

  Mazumder, Mohammad A Jafar ^a   Zahir, Hasan ^a   Zaman, Sharif F ^b  

^a KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS   (Saudi Arabia)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cationic polymers; Cytotoxicity; Dna plasmid; Gene delivery; Lipid; Polymer therapeutics; Transfection

Indexed keywords

CYTOTOXICITY; DISEASES; FUNCTIONAL POLYMERS; GENE EXPRESSION; GENE THERAPY; LIPIDS;

CATIONIC POLYMERS; DNA PLASMIDS; GENE DELIVERY; POLYMER THERAPEUTICS; TRANSFECTION;

GENE TRANSFER;

EID: 84905740659     PISSN: 10226680     EISSN: 16628985     Source Type: Book Series    
DOI: 10.4028/www.scientific.net/AMR.995.29     Document Type: Article

References (142)

1. M. Nishikawa, Y. Takakura, M. Hashida, Pharmacokinetic considerations regarding nonviral cancer gene therapy, Cancer Sci. 99 (2008) 856-862.
2. S. Yla-Herttuala, K. Alitalo, Gene transfer as a tool to induce therapeutic vascular growth, Nat. Med. 9 (2003) 694-701.
3. H. Huebner, Cell encapsulation in animal cell biotechnology: Methods and Protocols, 24 (2007) 179-191.
4. D.K. Armstrong, S. Cunningham, J.C. Davies, E.W.F.W. Alton, Gene therapy in cystic fibrosis, Arch. Dis. Child. (2014) doi: 10.1136/archdischild-2012-302158.
5. R. Aggarwal, A. Prakash, M. Aggarwal, Thalassemia: An overview, J. Sci. Soc. 41 (2014) 3-6.
6. R.J. Fairclough, M.J. Wood, K.E. Davies, Therapy for duchenne muscular dystrophy: renewed optimism from genetic approaches, Nature Rev. Genetics, 14 (2013) 373-378.
7. S.L. Ginn, I.E. Alexander, M.L. Edelstein, M.R. Abedi, J. Wixon, Gene therapy clinical trials worldwide to 2012- an update, J. Gene Med. 15(2), (2013) 65-77.
8. J.M. Stribley, K.S. Rehman, H. Niu, G.M. Christman, Gene therapy and reproductive medicine, Fertil. Steril. 77 (2002) 645-657.
9. M.B. Asparuhova, I. Barde, D. Trono, K. Schranz, D.J. Schumperli, Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication, J. Gene Med. 10 (2008) 1059-1070.
10. F.D. Ledley, Pharmaceutical approach to somatic gene therapy, Pharm. Res. 13 (1996) 1595-1614.
11. T. Friedmann, R. Roblin, Gene therapy for human genetic disease, Science 175 (1972) 949-955.
12. E. Alton, Progress and Prospects: Gene Therapy Clinical Trials (Part 1), Gene Ther. 14(2007) 1439-1447.
13. J. Vacik, B.S. Dean, W.E. Zimmer, D.A. Dean, Cell-specific nuclear import of plasmid DNA, Gene Ther. 6 (1999) 1006-1014.
14. D.V. Schaffer, D.A. Lauffenburger, Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery, J. Biol. Chem. 273 (1998) 28004-28009.
15. A. Fasbender, J. Zabner, B.G. Zeither, M.J. Welsh, A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia, Gene Ther. 4 (1997) 1173-1180.
16. H. Matsui, L.G. Johnson, S.H. Randell, R.C. Boucher, Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells, J. Biol. Chem. 272 (1997) 1117-1126.
17. G.J. Nabel, Development of optimized vectors for gene therapy, Proc. Natl. Acad. Sci. USA. 96 (1999) 324-326.
18. L. Li, F. Saade, N. Petrovsky, The future of human DNA vaccines, J. Biotechnol. 162 (2012) 171-182.
19. D.A. Hullett, Gene therapy in transplantation, J. Heart Lung Transplant. 15 (1996) 857-862.
20. J.M. Stribley, K.S. Rehman, H. Niu, G.M. Christman. Gene therapy and reproductive medicine. Fertil. Steril. 77 (2002) 645-657.
21. L.S. Young, P.F. Searle, D. Onion, V. Mautner, Viral gene therapy strategies: from basic science to clinical application, J. Pathol. 208 (2006) 299-318.
22. C. Mueller, T.R. Flotte, Clinical gene therapy using recombinant adeno-associated virus vectors, Gene Ther. 15 (2008) 858-863.
23. S.A. Rosenberg, P. Aebersold, K. Cornetta, A. Kasid, R.A. Morgan, R. Moen, Gene transfer into human-immunotherapy of patients with advanced melanoma, using tumor infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323 (1990) 570-578.
24. N.A. Wivel, J.M. Wilson, Methods of gene delivery. Hematol. Oncol. Clin. North. Am. 12 (1998) 483-501.
25. M. Watanabe, Y. Nasu, H. Kumon, Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy, Oncol. Lett. 7 (2014) 595-601.
26. Z. Ram, K.W. Culver, E.M. Oshiro, J.J. Viola, H.L. DeVroom, E. Otto, Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells, Nature Med. 3 (1997) 1354-1361.
27. J.R. Herman, H.L. Adler, E. Aguilar- Cordova, A. Rojas-Martinez, S. Woo, T.L. Timme, M. Wheeler, T.C. Thompson, P.T. Scardino, Insitu gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum.Gene Ther. 10 (1999) 1239-1249.
28. F. McCormick, Cancer gene therapy, fringe or cutting edge, Nature Rev. Cancer 1 (2001) 130-141.
29. G.Y. Wu, J.M. Wilson, F. Salaby, M. Grossman, D.A. Shafritz, C.H. Wu, Receptormediated gene delivery in vivo: partial correction of genetic analbuminemia in nagase rats, J. Biol. Chem. 266 (1991) 14338-14342.
30. M.E. Gore, Adverse effects of gene therapy: gene therapy can cause leukaemia: no shock, mild horror but a probe, Gene Ther. 10 (2003) 4-16.
31. M. Mirjam, Nordling-David, G. Golomb, Gene delivery by liposomes, Israel J. Chem. 53 (2013) 737-747.
32. H. Lv, S. Zhang, B. Wang, S. Cui, J. Yan, Toxicity of cationic lipids and cationic polymers in gene delivery,J. Control Release 114 (2006) 100-109.
33. T. Ferkol, G.L. Lindberg, J. Chen, J.C. Perales, D.R. Crawford, O.D. Ratnoff, R.W. Hanson, Regulation of the phosphoenol pyruvate carboxykinase/human factor IX gene introduced into the livers of adult rats by receptor-mediated gene transfer, FASEB J. 7 (1993) 1081-1090.
34. D.W. Pack, A.S. Hoffman, S. Pun, P.S. Stayton, Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4 (2005) 581-593.
35. M. Lee, S.W. Kim, Polyethylene glycol-conjugated copolymers for plasmid DNA delivery, Pharm. Res. 22 (2005) 1-10.
36. S. Jiao, P. Williams, R.K. Berg, B.A. Hodgeman, L.J. Liu, G. Repetto, J.A. Wolff, Direct gene transfer into nonhuman primate myofibers in vivo. Hum. Gene Ther. 3 (1992) 21-33.
37. M.A. Hickman, R.W. Malone, K. Lehmann-Bruinsma, T.R. Sih, D. Knoell, F.C. Szoka, R. Walzem, D.M. Carlson, J.S. Powell, Gene expression following direct injection of DNA into liver. Hum. Gene Ther. 5 (1994) 1477-1483.
38. A. Ardehali, A. Fyfe, H. Laks, D.C. Drinkwater, J.H. Qiao, A.J. Lusis, Direct gene transfer into donor hearts at the time of harvest. J. Thorac. Cardiovasc. Surg. 109 (1995) 716-720.
39. R.G. Vile, I.R. Hart, Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53 (1993) 3860-3864.
40. J.B. Ulmer, J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felgner, V.J. Dwarki, Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 (1993) 1745-1749.
41. A. Rolland, Gene medicines: the end of the beginning, Adv. Drug Deliv. Rev. 57 (2005) 669-673.
42. W.F. Anderson, Human Gene Therapy, Nature 392 (1998) 25-30.
43. S. Han, R.I. Mahato, Y.K. Sung, S.W. Kim, Development of biomaterials for gene therapy, Mol. Ther. 2 (2000) 302-317.
44. J.A. Wolff, R.W. Malone, P. Williams, W. Chang, G. Acsadi, A. Jani, L. Philip, Direct gene transfer into mouse muscle in vivo,Science 247 (1990) 1465-1468.
45. M.L. Chang, J.L. Chen, C.T. Yeh, M.Y. Chang, C.K. Liang, C.T. Chiu, D.Y. Lin, Y.F. Liaw, Gene gun bombardment with DNA-coated gold particles is a potential alternative to hydrodynamics-based transfection for delivering genes into superficial hepatocytes, Hum. Gene. Ther. 19 (2008) 391-395.
46. I. Danko, J.A. Wolff, Direct gene transfer into muscle, Vaccine 12 (1994) 1499-1502.
47. A. Vaheri, J.S. Pagano, Infectious poliovirus RNA: a sensitive method of assay, Virology 27 (1965) 434-436.
48. F.L. Graham, A.J.V. Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology 52 (1973) 456-467.
49. C. Tros de Ilarduya, Y. Sun, N. Duzgunes, Gene delivery by lipoplexes and polyplexes, Eur. J. Pharm. Sci. 40 (2010) 159-170.
50. L. Wasungu, D. Hoekstra, Cationic lipids, lipoplexes and intracellular delivery of genes, J. Control Release, 116 (2006) 255-264.
51. E. Mayhew, D. Papajadjopoulos, Therapeutic applications of liposomes, in Liposomes, M. J. Ostro (Ed.), Marcel Dekker, New York, NY, USA, 1983.
52. P.L. Felgner, T.R. Gadek, M. Holm, Lipofection: a highly efficient, lipid-mediated DNAtransfection procedure, Proc. Natl Acad. Sci. USA 84 (1987) 7413-7417.
53. R. Leventis, J.R. Silvius, Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles, Biochimica et Biophysica Acta, 1023 (1990) 124-132.
54. X. Gao, L. Huang, A novel cationic liposome reagent for efficient transfection of mammalian cells, Biochemical and Biophysical Research Communications, 179 (1991) 280-285.
55. J.-P. Behr, B. Dementia, J.-P. Loeffler, J. Perez-Mutul, Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA, Proc. Natl Acad. Sci. USA 86 (1989) 6982-6986.
56. H. Farhood, N. Serbina, L. Huang, The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer, Biochimica et Biophysica Acta, 1235 (1995) 289-295.
57. T. Ren, Y.K. Song, G. Zhang, D. Liu, Structural basis of DOTMA for its high intravenous transfection activity in mouse, Gene Ther. 7 (2000) 764-768.
58. S. Jain, G. Zon, M. Sundaralingam, Base only binding of spermine in the deep groove of the A-DNA octamer d(GTGTACAC), Biochemistry 28 (1989) 2360-2364.
59. N. Zhu, D. Liggit, Y. Liu, R. Debs, Systemetric gene expression after intravenous DNA delivery into adult mice, Science 261 (1993) 209-211.
60. Y. Wang, H.H. Su, Y. Yang, Y. Hu, L. Zhang, P. Blancafort, L. Huang, Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy, Mol. Ther. 21 (2013) 358-367.
61. X. Gao, L. Huang, A novel cationic liposome reagent for efficient transfection of mammalian cells, Biochemical and Biophysical Research Communications 179 (1991) 280-285.
62. S. Ajmani, J.A. Hughes, 3β [N-(NM′, N′-dimethylaminoethane)-carbamoyl] cholesterol (DC-chol)-mediated gene delivery to primary rat neurons: characterization and mechanism, Neurochemical Research 24 (1999) 699-703.
63. J.M. Metselaar, P. Bruin, L.W.T. De Boer, A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity, Bioconjugate Chem. 14 (2003) 1156-1164.
64. J.-K. Kim, S.-H. Choi, C.-O. Kim, J.-S. Park, W.-S. Ahn, C.-K. Kim, Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency, J. Pharmacy and Pharmacology, 55 (2003) 453-460.
65. D. Needham, T.J. McIntosh, D.D. Lasic, Repulsive interactions and mechanical stability of polymer-grafted lipid membranes, Biochimica et Biophysica Acta, 1108 (1992) 40-48.
66. F. Shi, L. Wasungu, A. Nomden, Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and nonlamellar transitions, Biochemical Journal, 366 (2002) 333-341.
67. C. Srinivasan, D.J. Burgess, Optimization and characterization of anionic lipoplexes for gene delivery, J. Control Release 136 (2009) 62-70.
68. C. Nicolau, A.L. Pape, P. Soriano, F. Fargette, M.F. Juhel, In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I, Proc. Natl Acad. Sci. USA 80 (1983), 1068-1072.
69. F.D. Ledley, Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum. Gene Ther. 6 (1995) 1129-1144.
70. S.D. Patil, D.G. Rhodes, D.J. Burgess, Biophysical characterization of anionic lipoplexes, BBA 1711 (2005) 1-11.
71. S.D. Patil, D.G. Rhodes, D.J. Burgess, Anionic liposomal delivery system for DNA transfection, AAPS J. 6 (2004) e29.
72. H.C. Kang, K.M. Huh, Y.H. Bae, Polymeric nucleic acid carrier: Current issues and novel design approaches, J. Control. Release 164 (2012) 256-264.
73. C.L. Gebhart, A.V. Kabanov, Evaluation of polyplexes as gene transfer agents, J. Controll. Rel. 73 (2001) 401-416.
74. T.G. Park, J.H. Jeong, S.W. Kim, Current status of polymeric gene delivery systems, Adv. Drug Deliv. Rev. 58 (2006) 467-486.
75. T. Kushibiki, N. Nagata-Nakajima, M. Sugai, A. Shimizu, Y. Tabata, Delivery of plasmid DNA expressing small interference RNA for TGF-β type II receptor by cationized gelatin to prevent interstitial renal fibrosis, J. Control. Release 105 (2005) 318-331.
76. J. Wang, I.L. Lee, W.S. Lim, S.M. Chia, H. Yu, K.W. Leong, H.Q. Mao, Evaluation of collagen and methylated collagen as gene carriers, Int. J. Pharm. 279 (2004) 115-126.
77. F. Abedini, H. Hosseinkhani, M. Ismail, Y.-R. Chen, A.R. Omar, P.P. Chong, A.J. Domb, In vitro intracellular trafficking of biodegradable nanoparticles of dextran-spermine in cancer cell lines, Int. J. Nanotechnol. 8 (2011) 712-723.
78. J.J. Thomas, M.R. Rekha, C.P. Sharma, Unraveling the intracellular efficacy of dextranhistidine polycation as an efficient nonviral gene delivery system, Mol. Pharm. 9 (2012) 121-134.
79. Y. Song, H. Wang, X. Zeng, Y. Sun, X. Zhang, J. Zhou, L. Zhang, Effect of molecular weight and degree of substitution of quaternized cellulose on the efficiency of gene transfection, Bioconjugate Chem. 21 (2010) 1271-1279.
80. M. Koping-Hoggard, I. Tubulekas, H. Guan, K. Edwards, M. Nilsson, K.M. Varum, P. Artursson, Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo, Gene Ther. 8 (2001) 1108-1121.
81. K. Bowman, K.W. Leong, Chitosan nanoparticles for oral drug and gene delivery, Int. J Nanomedicine 1 (2006) 117-128.
82. J.M. Dang, K.W. Leong, Natural polymers for gene delivery and tissue engineering, Adv. Drug Deliv. Rev. 58 (2006) 487-499.
83. K. Chaturvedi, K. Ganguly, A.R. Kulkarni, V.H. Kulkarni, M.N. Nadagouda, W.E. Rudzinski, T.M. Aminabhavi, Cyclodextrin based siRNA delivery nanocarriers: a state-ofthe- art review, Expert. Opin. Drug Deliv. 8 (2011) 1455-1468.
84. H. Gonzalez, S.J. Hwang, M.E. Davis, New class of polymers for the delivery of macromolecular therapeutics, Bioconjug. Chem. 10 (1999) 1068-1074.
85. S.H. Pun, N.C. Bellocq, A. Liu, G. Jensen, T. Machemer, E. Quijano, T. Schluep, S. Wen, H. Engler, J. Heidel, M.E. Davis, Cyclodextrin-modified polyethylenimine polymers for gene delivery, Bioconjugate Chem. 15 (2004) 831-840.
86. P. Hiwale, S. Lampis, G. Conti, C. Caddeo, S. Murgia, A.M. Fadda, M. Monduzzi, In vitro release of lysozyme from gelatin microspheres: Effect of cross-linking agents and thermoreversible gel as suspending medium, Biomacromolecules 12 (2011) 3186-3193.
87. C.Y. Li, W. Yuan, H. Jiang, J.S. Li, F.J. Xu, W.T. Yang, J. Ma, PCL film surfaces conjugated with P(DMAEMA)/Gelatin complexes for improving cell immobilization and gene transfection, Bioconjugate Chem. 22 (2011) 1842-1851.
88. K. Morimoto, S. Chono, T. Kosai, T. Seki, Y. Tabata, Design of cationic microspheres based on aminated gelatin for controlled release of peptide and protein drugs, Drug Deliv. 15 (2008) 113-117.
89. X. Xu, R.M. Capito, M. Spector, Delivery of plasmid IGF-1 to chondrocytes via cationized gelatin nanoparticles, J. Biomed. Mater. Res. Part A 84A (2008) 73-83.
90. S. Inada, H. Fujiwara, K. Atsuji, K. Takashima, Y. Araki, T. Kubota, Y. Tabata, H. Yamagishi, Successful gene transfer into dendritic cells with cationized gelatin and plasmid DNA complexes via a phagocytosis-dependent mechanism, Anticancer Res. 26 (2006) 1957-1963.
91. H. Fujii, A. Matsuyama, H. Komoda, M. Sasai, M. Suzuki, T. Asano, Y. Doki, M. Kirihata, K. Ono, Y. Tabata, Y. Kaneda, Y. Sawa, C.M. Lee, Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo, Radiat. Oncol. 6 (2011) 8.
92. P.G. Rigby, Prolongation of Survival of Tumour-bearing Animals by Transfer of "Immune" RNA with DEAE Dextran, Nature 221 (1969) 968-969.
93. T. Azzam, H. Eliyahu, A. Makovitzki, M. Linial, A.J. Domb, Hydrophobized dextranspermine conjugate as potential vector for in vitro gene transfection, J. Control Release 96 (2004) 309-323.
94. Y. Song, L. Zhang, W. Gan, J. Zhou, L. Zhang, Self-assembled micelles based on hydrophobically modified quaternized cellulose for drug delivery, Colloids Surf., B 83 (2011) 313-320.
95. Y. Song, Y. Sun, X. Zhang, J. Zhou, L. Zhang, Homogeneous quaternization of cellulose in NaOH/urea aqueous solutions as gene carriers, Biomacromolecules 9 (2008) 2259-2264.
96. S.B. Rao, C.P. Sharma, Use of chitosan as a biomaterial: studies on its safety and hemostatic potential, J. Biomed. Mater. Res. 34 (1997) 21-28.
97. T.J. Aspden, J.D. Mason, N.S. Jones, J. Lowe, O. Skaugrud, L. Illum, Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers, J. Pharm. Sci. 86 (1997) 509-513.
98. N. Bhattarai, J. Gunn, M. Zhang, Chitosan-based hydrogels for controlled, localized drug delivery, Adv. Drug Deliv. Rev. 62 (2010) 83-99.
99. P. Erbacher, S. Zou, T. Bettinger, A.M. Steffan, J.S. Remy, Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability, Pharm. Res. 15 (1998) 1332-1339.
100. R. Belalia, S. Grelier, M. Benaissa, V. Coma, New bioactive biomaterials based on quaternized chitosan, J. Agric. Food Chem. 56 (2008) 1582-1588.
101. A. Kabanov, J. Zhu, V. Alakhov, Pluronic block copolymers for gene delivery, Adv. Genet. 53 (2005) 231-261.
102. A. El-Aneed, An overview of current delivery systems in cancer gene therapy, J. Control. Release 94 (2004) 1-14.
103. E.D. Ivanova, N.I. Ivanova, M.D. Apostolova, S.C. Turmanova, I.V. Dimitrov, Polymer gene delivery vectors encapsulated in thermally sensitive bioreducible shell, Bioorg. Med. Chem. Lett. 23 (2013) 4080-4084.
104. S.C. De Smedt, J. Demeester, W.E. Hennink, Cationic polymer based gene delivery systems, Pharm. Res. 17 (2000) 113-126.
105. K. Maruyama, T. Takizawa, T. Yuda, S.J. Kennel, L. Huang, M. Iwatsuru, Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies, BBA 1234 (1995) 74-80.
106. B. Brissault, A. Kichler, C. Guis, C. Leborgue, D. Danos, H. Charadame, synthesis of linear polyethyleneimine derivatives for DNA transfection, Bioconjugate Chem. 14 (2003) 581-587.
107. C.M. Ward, M.L. Read, L.W. Seymour, Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy, Blood 97 (2001) 2221-2229.
108. S.Y. Tzeng, H. Guerrero-Cázares, E.E. Martinez, J.C. Sunshine, A. Quiñones-Hinojosa, J.J. Green, Non-viral gene delivery nanoparticles based on Poly (β-amino esters) for treatment of glioblastoma, Biomaterials 32 (2011) 5402-5410.
109. N. Montserrat, E. Garreta, F. González, J. Gutiérrez, C. Eguizábal, V. Ramos, S. Borro, J.C.I. Belmonte, Simple Generation of Human Induced Pluripotent Stem Cells Using Poly- β-amino Esters As the Non-viral Gene Delivery System, J. Biol. Chem. 286 (2011) 12417-12428.
110. K.C. Wood, S.R. Little, R. Langer, P.T. Hammond, A family of hierarchically selfassembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery, Angew. Chem. Int. Edn. 44 (2005) 6704-6708.
111. O. Boussif, F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, J.P. Behr, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92 (1995) 7297-7301.
112. H.J. Kim, M.S. Kwon, J.S. Choi, B.H. Kim, J.K. Yoon, K. Kim, J.-S. Park, Synthesis and characterization of degradable polycationic polymers as gene delivery carriers, Bull. Korean Chem. Soc. 28 (2007) 63-67.
113. M.A. Gosselin, W. Guo, R.J. Lee, Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine, Bioconjugate Chem. 12 (2001) 989-994.
114. M.A. Wolfert, P.R. Dash, O. Nazarova, D. Oupický, L.W. Seymour, S. Smart, J. Strohalm, K. Ulbrich, Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA, Bioconjugate Chem. 10 (1999) 993-1004.
115. U.K. Laemmli, Characterization of DNA condensates induced by poly(ethylene oxide) and poly-L-lysine, Proc. Natl. Acad. Sci. USA 72 (1975) 4288-4292.
116. Y.H. Choi, F. Liu, J.S. Kim, Y.K. Choi, J.S. Park, S.W. Kim, Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrier, J. Control. Release 54 (1998) 39-48.
117. M. Morille, C. Passirani, A. Vonarbourg, A. Clavreul, J.P. Benoit, Progress in developing cationic vectors for non-viral systemic gene therapy against cancer, Biomaterials 29 (2008) 3477-3496.
118. A. Akinc, D.G. Anderson, D.M. Lynn, R. Langer, Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery, Bioconjugate Chem. 14 (2003) 979-988.
119. D.M. Lynn, R. Langer, Degradable poly(β-amino esters): Synthesis, characterization, and self-assembly with plasmid DNA, J. Am. Chem. Soc. 122 (2000) 10761-10768.
120. J.F. Kukowska-Latallo, A.U. Bielinska, J. Johnson, R. Spindler, D.A. Tomalia, J.R. Baker Jr, Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers, Proc. Natl. Acad. Sci. USA93 (1996) 4897-4902.
121. M.X. Tang, C.T. Redemann, F.C. Szoka, In vitro gene delivery by degradedpolyamidoamine dendrimers, Bioconjug. Chem. 7 (1996) 703-714.
122. M. Singh, M. Briones, G. Ott, D. O'Hagan, Cationic microparticles: A potent delivery system for DNA vaccines, Proc. Natl. Acad. Sci. USA 97 (2000) 811-816.
123. C.G. Oster, N. Kim, L. Grode, L. Barbu-Tudoran, A.K. Schaper, S.H.E. Kaufmann, T. Kissel, Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethyleneimine as carriers systems for parental DNA vaccination, J. Control. Release 104 (2005) 359-377.
124. S. Li, Z. Ma, Nonviral gene therapy, Curr. Gene Ther. 1 (2001) 201-226.
125. A.M. Funhoff, S. Monge, R. Teeuwen, G.A. Koning, N.M.E. Schuurmans-Nieuwenbroek, D.J.A. Crommelin, D.M. Haddleton, W.E. Hennink, C.F.V. Nostrum, PEG shielded polymeric double-layered micelles for gene delivery, J. Control. Rel. 102 (2005) 711-724.
126. U. Rungsardthong, M. Deshpande, L. Bailey, M. Vamvakaki, S.P. Armes, M.C. Garnett, S. Stolnik, Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy, J. Control. Release 73 (2001) 359-380.
127. W. Miao, G. Shim, S. Lee, Y.-K. Oh, Structure-dependent photo thermal anticancer effects of carbon-based photo-responsive nanomaterials, Biomaterials 35 (2014) 4058-4065.
128. J.F. Tan, R. Ravi, H.P. Too, T.A. Hatoon, K.C. Tam, Association behavior of biotinylated and non-biotinylated poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate), Biomacromolecules 6 (2005) 498-506.
129. M. Iijima, Y. Nagasaki, T. Okada, M. Kato, K. Kataoka, Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers, Macromolecules 32 (1999) 1140-1146.
130. K. Matsumoto, H. Matsuoa, Synthesis of core-crosslinked carbosilane block copolymer micelles and their thermal transformation to silicon-based ceramics nanoparticles, J. Polym. Sci. Part A: Polym. Chem. 43 (2005) 3778-3787.
131. F. Henselwood, G. Liu, Water-soluble nanospheres of poly(2-cinnamoylethyl methacrylate) - block-poly(acrylic acid), Macromolecules 30 (1997) 488-493.
132. G. Liu, Diblock copolymer nanostructures, Macromol. Symp.113 (1997) 233-248.
133. Q.G. Ma, E.E. Remsen, T. Kowalewski, K.L. Wooley, Two-dimensional, shell-cross-linked nanoparticle arrays, J. Am Chem. Soc.123 (2001) 4627-4628.
134. Y. Wang, L.S. Wang, S.H. Goh, Y.Y. Yang, Synthesis and characterization of cationic micelles self-assembled from a biodegradable copolymer for gene delivery, Biomacromolecules 8 (2007) 1028-1037.
135. Y. Wang, S. Gao, W.H. Ye, S.H. Yoon, Y.Y. Yang, Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer, Nat. Mater. 5 (2006) 791-796.
136. W.F. Anderson, Human Gene Therapy, Nature 392 (1998) 25-30.
137. G. Bauer, J.S. Anderson, Clinical applications of HIV gene therapy in gene therapy for HIV, Biochem. Molecular Biol. 8 (2014) 55-62.
138. M.J. Wright, E. Rosenthal, L. Stewart, L.M.L. Wightman, A.D. Miller, D.S. Latchman, M.S. Marber, Marber, β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale, Gene Ther. 5 (1998) 301-308.
139. S.K. Tripathy, H.B. Black, E. Goldwasser, J.M. Leiden, Immune responses to transgeneencoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors, Nature Med. 2 (1996) 545-550.
140. M.J. Mann, G.H. Gibbons, H. Hutchinson, R.S. Poston, E.G. Hoyt, R.C. Robbins, V.J. Dzau, Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues, Proc. Natl. Acad. Sci. USA 96 (1999) 6411-6416.
141. M. Cavazzana-Calvo, A. Thrasher, F. Mavilio, The future of gene therapy, Nature 427 (2004) 779-781.
142. F.J. Verban, I.M. Van Dam, Y. Takakura, M. Hashida, W.E. Hennink, G. Storm, C. Oussoren, Intravenous fate of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes, Eur. J. Pharm. Sci. 20 (2003) 419-427.